The upside numbers are very big on this one, and the current market cap is tiny.
The other advantage is that this is not an early stage bio where you have to wait 10 years. This will push higher as the sales come in and more distributor deals are signed.
Listening to the BRR interview, it sounds like more deals are coming any day as well.
